FABIOR
Drug
Mayne Pharma Inc.
Total Payments
$61,022
Transactions
346
Doctors
126
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $1,985 | 4 | 3 |
| 2020 | $27,468 | 280 | 88 |
| 2019 | $21,697 | 18 | 6 |
| 2018 | $9,762 | 9 | 9 |
| 2017 | $109.96 | 35 | 29 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $41,634 | 36 | 68.2% |
| Unspecified | $8,602 | 2 | 14.1% |
| Consulting Fee | $6,050 | 1 | 9.9% |
| Food and Beverage | $3,503 | 267 | 5.7% |
| Gift | $1,075 | 1 | 1.8% |
| Education | $95.00 | 38 | 0.2% |
| Travel and Lodging | $62.80 | 1 | 0.1% |
Payments by Type
General
$52,420
344 transactions
Research
$8,602
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Efficacy of tazarotene foam vs vehicle in treatment of facial photodamage | Mayne Pharma Inc. | $5,376 | 1 |
| Use of Fabior for keratoderma for psorisis | Mayne Pharma Inc. | $3,226 | 1 |
Top Doctors Receiving Payments for FABIOR — Page 5
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Dermatology | The Woodlands, TX | $3.72 | 1 |
| , M.D | Dermatology | New Orleans, LA | $3.26 | 1 |
| , M.D | Dermatology | Houston, TX | $2.50 | 1 |
| , M.D | MOHS-Micrographic Surgery | Malibu, CA | $2.50 | 1 |
| , DO | Dermatology | Deltona, FL | $2.50 | 1 |
| , MD | Dermatology | Orlando, FL | $2.50 | 1 |
| , M..D | Dermatology | Santa Monica, CA | $2.50 | 1 |
| , MD | Dermatology | Viera, FL | $2.50 | 1 |
| , MD | Dermatology | Long Beach, NY | $2.50 | 1 |
| Alex Khadavi | — | Encino, CA | $2.50 | 1 |
| , M.D | Procedural Dermatology | Beverly Hills, CA | $2.50 | 1 |
| , M.D | Dermatology | Tavares, FL | $2.50 | 1 |
| , MD | Dermatology | Beverly Hills, CA | $2.50 | 1 |
| , M.D | Dermatology | Ocala, FL | $2.50 | 1 |
| , M.D | Dermatology | Studio City, CA | $2.50 | 1 |
| , M.D | Procedural Dermatology | Upland, CA | $2.50 | 1 |
| , MD | Dermatology | Spring, TX | $2.50 | 1 |
| , M.D | Dermatology | St Louis, MO | $2.50 | 1 |
| , M.D | Dermatology | Burbank, CA | $2.50 | 1 |
| , M.D | Dermatology | Houston, TX | $2.50 | 1 |
| , MD | Dermatology | Saint Louis, MO | $2.50 | 1 |
| , M.D | Specialist | Encino, CA | $2.50 | 1 |
| , M.D | Dermatology | Melbourne, FL | $2.50 | 1 |
| , D.O | Dermatology | Melbourne, FL | $2.50 | 1 |
| , MD | Dermatology | Kirkwood, MO | $2.50 | 1 |
Ad
Manufacturing Companies
- Mayne Pharma Inc. $31,462
- MAYNE PHARMA INC. $29,453
- GlaxoSmithKline, LLC. $107.07
Product Information
- Type Drug
- Total Payments $61,022
- Total Doctors 126
- Transactions 346
About FABIOR
FABIOR is a drug associated with $61,022 in payments to 126 healthcare providers, recorded across 346 transactions in the CMS Open Payments database. The primary manufacturer is Mayne Pharma Inc..
Payment data is available from 2017 to 2021. In 2021, $1,985 was paid across 4 transactions to 3 doctors.
The most common payment nature for FABIOR is "Honoraria" ($41,634, 68.2% of total).
FABIOR is associated with 2 research studies, including "Efficacy of tazarotene foam vs vehicle in treatment of facial photodamage" ($5,376).